Heather Preston, Director at Karuna Therapeutics, Inc. (KRTX), bought 788 shares at $70.50 ($56K) on 2020-01-09, disclosed to the SEC on 2020-01-10.
Open-market purchase of $56k KRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| AKUS | BUY | 2020-07-02 | $5.1M | — | Filing → |
| KRTX | BUY | 2020-03-12 | $227K | — | Filing → |
| KRTX | BUY | 2020-01-07 | $100K | — | Filing → |